Related Experiment Video
Updated: Nov 9, 2025

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
Hypoproteinemia predicts disease severity and mortality in COVID-19: a call for action
Amira Mohammed Ali1,2, Hiroshi Kunugi3,4
1Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. mercy.ofheaven2000@gmail.com.
Insights
Hypoproteinemia, or low protein levels, is common in hospitalized COVID-19 patients. This condition contributes to disease severity and adverse outcomes, particularly in older adults.
Area of Science:
- Biochemistry
- Immunology
- Critical Care Medicine
Background:
- Proteins are essential for tissue structure and cellular signaling.
- Coronavirus disease 2019 (COVID-19) is linked to high mortality, especially in the elderly, often due to lung damage and organ failure.
- COVID-19 induces a hypercatabolic state, leading to significant protein loss.
Discussion:
- This review examines hypoproteinemia in symptomatic and hospitalized COVID-19 patients.
- It focuses on the underlying pathophysiology, diagnostic screening methods, and the impact on disease progression.
- The role of hypoproteinemia in COVID-19 severity and adverse effects is critically analyzed.
Key Insights:
- Hypoproteinemia is a significant complication in COVID-19 patients.
- Low protein levels are associated with increased disease severity and poorer outcomes.
- Understanding hypoproteinemia is crucial for managing COVID-19 patients.
Outlook:
- Further research into the mechanisms linking hypoproteinemia and COVID-19 severity is warranted.
- Development of targeted interventions to address protein loss in COVID-19 patients may improve outcomes.
- Clinical guidelines should consider screening for and managing hypoproteinemia in hospitalized COVID-19 cases.
Abstract:
Proteins represent the major building blocks of body tissues, and they regulate signaling involved in most cellular activities. Coronavirus disease 2019 (COVID-19) infection has been associated with high fatality, especially among older adults. The main cause of death is pulmonary tissue damage and multiple organ failure. The disease is associated with a hypercatabolic state that entails excessive protein loss. This review commentary sheds the light on hypoproteinemia in symptomatic/hospitalized COVID-19 with a special emphasis on its pathophysiology, screening, as well as its contribution to disease severity and adverse effects.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

